AI Apexigen, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Apexigen, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 25 August 2023 (Retenue fiscale). Among the most active insiders: Sarena Francis Willard. The full history is free.
Analyst consensus: bullish or bearish? Analysts rate Apexigen, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 August 2023
All Executives26 Thresholds0 Prospectus0 Other0
Declarations 26 total
● President and COO · Executives · 23 Aug 2023
31,123 shares @ US$0.3851 52.5% of flow Common Stock SEC:0001209191-23-047439:0
● SVP, Finance and Operations · Executives · 23 Aug 2023
15,561 shares @ US$0.3851 57.5% of flow Common Stock SEC:0001209191-23-047441:0
● Chief Financial Officer · Executives · 23 Aug 2023
26,416 shares @ US$0.3851 59.1% of flow Common Stock SEC:0001209191-23-047432:0
● Director · Executives · 23 Aug 2023
10,000 shares Common Stock SEC:0001209191-23-047450:0
● Director · Executives · 23 Aug 2023
146,383 shares Common Stock SEC:0001209191-23-047454:0
● Chief Medical Officer · Executives · 23 Aug 2023
16,354 shares Common Stock SEC:0001209191-23-047436:0
◆ Chief Executive Officer · Executives · 23 Aug 2023
400,000 shares 0Common Stock SEC:0001209191-23-047429:0
● Chief Medical Officer · Executives · 15 Jun 2023
4,323 shares @ US$0.4911 31.1% of flow Common Stock SEC:0001209191-23-039492:0
● SVP, Finance and Operations · Executives · 15 Jun 2023
2,777 shares @ US$0.4911 13.0% of flow Common Stock SEC:0001209191-23-039497:0
● Chief Executive Officer · Executives · 15 Jun 2023
7,001 shares @ US$0.4911 31.1% of flow Common Stock SEC:0001209191-23-039499:0
● Chief Financial Officer · Executives · 15 Jun 2023
4,504 shares @ US$0.4911 12.7% of flow Common Stock SEC:0001209191-23-039489:0
● President and COO · Executives · 15 Jun 2023
6,917 shares @ US$0.4911 14.8% of flow Common Stock SEC:0001209191-23-039495:0
◆ Chief Financial Officer · Executives · 23 May 2023
150,000 shares 0Common Stock SEC:0001209191-23-032167:0
◆ President and COO · Executives · 23 May 2023
150,000 shares 0Common Stock SEC:0001209191-23-032162:0
◆ SVP, Finance and Operations · Executives · 23 May 2023
75,000 shares 0Common Stock SEC:0001209191-23-032173:0
● Director · Executives · 26 Jan 2023
146,383 shares 0Common Stock SEC:0001209191-23-031779:0
● Chief Financial Officer · Executives · 15 Dec 2022
4,503 shares @ US$1.06 28.2% of flow Common Stock SEC:0001209191-22-061975:0
● Chief Medical Officer · Executives · 15 Dec 2022
4,323 shares @ US$1.06 68.9% of flow Common Stock SEC:0001209191-22-062002:0
● Chief Executive Officer · Executives · 15 Dec 2022
7,001 shares @ US$1.06 68.9% of flow Common Stock SEC:0001209191-22-061966:0
● Chief Operating Officer · Executives · 15 Dec 2022
6,916 shares @ US$1.06 32.7% of flow Common Stock SEC:0001209191-22-062004:0
● SVP, Finance and Operations · Executives · 15 Dec 2022
2,851 shares @ US$1.06 29.5% of flow Common Stock SEC:0001209191-22-062008:0
◆ Chief Operating Officer · Executives · 7 Oct 2022
40,000 shares 0Common Stock SEC:0001209191-22-053349:0
◆ SVP, Finance and Operations · Executives · 7 Oct 2022
16,488 shares 0Common Stock SEC:0001209191-22-053351:0
◆ Chief Financial Officer · Executives · 7 Oct 2022
30,685 shares 0Common Stock SEC:0001209191-22-053342:0
◆ Chief Medical Officer · Executives · 7 Oct 2022
25,000 shares 0Common Stock SEC:0001209191-22-053346:0
25 of 26 declarations
Load more (1 remaining) 关于 Apexigen, Inc. Apexigen, Inc. 是一家生物制药公司，专注于开发免疫肿瘤治疗方法。它利用其药物发现平台来创建靶向肿瘤的治疗性抗体。